Open AccessSurvival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
Author(s) -
Funda MericBernstam,
Xiaofeng Zheng,
Maryam Shariati,
Senthil Damodaran,
Chetna Wathoo,
Lauren Brusco,
Mehmet Esat Demirhan,
Coya Tapia,
Agda Karina Eterovic,
Reva Basho,
Naoto T. Ueno,
Filip Janků,
Ayşegül Şahin,
Jordi Rodón,
Russell Broaddus,
Tae Beom Kim,
John Mendelsohn,
Kenna Shaw,
Debu Tripathy,
Gordon B. Mills,
Ken Chen
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00245
Subject(s) - oncology , breast cancer , medicine , metastatic breast cancer , mutation , cancer , overall survival , biology , genetics , gene
We sought to determine the significant genomic alterations in patients with metastatic breast cancer (MBC), and survival outcomes in common genotypes.